Ligand-dependent Inhibition of Oligomerization at the Human Thyrotropin Receptor*

Recently, several studies have reported oligomerization of G protein-coupled receptors, although the functional implications of this phenomenon are still unclear. Using fluorescence resonance energy transfer (FRET) and coimmunoprecipitation (COIP), we previously reported that the human thyrotropin (TSH) receptor tagged with green fluorescent protein (TSHRGFP) and expressed in a heterologous system was present as oligomeric complexes on the cell surface. Here, we have extended this biophysical and biochemical approach to study the regulation of such oligomeric complexes. Co-expression of TSHRGFP and TSHRMyc constructs in Chinese hamster ovary cells resulted in FRET-positive cells. The specificity of the FRET signal was verified by the absence of energy transfer in individually transfected TSHRGFP and TSHRMyc:Cy3 cells cultured together and also by acceptor photobleaching. Occupation of the receptor molecule by the ligand (TSH) resulted in a dose-dependent decrease in the FRET index from 20% in the absence of TSH to <1% with 103 microunits/ml of TSH. Such reduction in oligomeric forms was also confirmed by coimmunoprecipitation. Exposure of TSHRGFP/Myc cells to forskolin or cytochalasin D caused no change in the FRET index, confirming that the decrease in the oligomeric complexes was a receptor-dependent phenomenon and free of energy or microtuble requirements. The TSH-induced decrease in TSHR oligomers was found to be secondary to dissociation of the TSHR complexes as evidenced by an increase in fluorescent intensity of photobleached spots of GFP fluorescence with 103microunits/ml of TSH. These data indicated that the less active conformation of the TSHR was comprised of receptor complexes and that such complexes were dissociated on the binding of ligand. Such observations support the concept of a constitutively active TSHR dimer or monomer that is naturally inhibited by the formation of higher order complexes. Inhibition of these oligomeric forms by ligand binding returns the TSHR to an activated state.

[1]  F. Kolisis,et al.  Studies on the catalytic behaviour of a cholinesterase-like abzyme in an AOT microemulsion system. , 2002, Journal of biotechnology.

[2]  B. Weintraub,et al.  Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. , 2002, Physiological reviews.

[3]  L. Miller,et al.  Agonist-dependent Dissociation of Oligomeric Complexes of G Protein-coupled Cholecystokinin Receptors Demonstrated in Living Cells Using Bioluminescence Resonance Energy Transfer* , 2001, The Journal of Biological Chemistry.

[4]  R. Latif,et al.  Oligomerization of the Human Thyrotropin Receptor , 2001, The Journal of Biological Chemistry.

[5]  L. Devi,et al.  G-protein-coupled receptor dimerization: modulation of receptor function. , 2001, Pharmacology & therapeutics.

[6]  P. Pauwels,et al.  Agonist‐independent and ‐dependent oligomerization of dopamine D2 receptors by fusion to fluorescent proteins , 2001, FEBS letters.

[7]  Richard N. Day,et al.  Fluorescence resonance energy transfer microscopy of localized protein interactions in the living cell nucleus. , 2001, Methods.

[8]  M. Ikura,et al.  The use of FRET imaging microscopy to detect protein-protein interactions and protein conformational changes in vivo. , 2001, Current opinion in structural biology.

[9]  R. Tsien,et al.  Fluorescence resonance energy transfer analysis of cell surface receptor interactions and signaling using spectral variants of the green fluorescent protein. , 2001, Cytometry.

[10]  A. Kenworthy,et al.  Imaging protein-protein interactions using fluorescence resonance energy transfer microscopy. , 2001, Methods.

[11]  A. Periasamy,et al.  Fluorescence resonance energy transfer microscopy: a mini review. , 2001, Journal of biomedical optics.

[12]  J. Lippincott-Schwartz,et al.  Studying protein dynamics in living cells , 2001, Nature Reviews Molecular Cell Biology.

[13]  Lakshmi A. Devi,et al.  G protein coupled receptor dimerization: implications in modulating receptor function , 2001, Journal of Molecular Medicine.

[14]  S. Rees,et al.  Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer , 2001, The Journal of Biological Chemistry.

[15]  A. Hanyaloglu,et al.  Constitutive and Agonist-dependent Homo-oligomerization of the Thyrotropin-releasing Hormone Receptor , 2001, The Journal of Biological Chemistry.

[16]  Michel Bouvier,et al.  Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.

[17]  A. Cornea,et al.  Gonadotropin-releasing Hormone Receptor Microaggregation , 2001, The Journal of Biological Chemistry.

[18]  L. Devi,et al.  Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  P J Verveer,et al.  Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane. , 2000, Science.

[20]  L. Ma,et al.  Identification of G protein-coupled receptor kinase 2 phosphorylation sites responsible for agonist-stimulated delta-opioid receptor phosphorylation. , 2000, Molecular pharmacology.

[21]  B. O'dowd,et al.  Oligomerization of Dopamine and Serotonin Receptors , 2000, Neuropsychopharmacology.

[22]  Lakshmi A Devi,et al.  Dimerization of G-Protein Coupled Receptors , 2000, Neuropsychopharmacology.

[23]  L. Devi.  G-protein-coupled receptor dimers in the lime light. , 2000, Trends in pharmacological sciences.

[24]  B. O'dowd,et al.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.

[25]  B. O'dowd,et al.  The splice variant D3nf reduces ligand binding to the D3 dopamine receptor: evidence for heterooligomerization. , 2000, Brain research. Molecular brain research.

[26]  H. Akil,et al.  Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. , 2000, Molecular pharmacology.

[27]  Michel Bouvier,et al.  Functional Significance of Oligomerization of G-protein-coupled Receptors , 2000, Trends in Endocrinology & Metabolism.

[28]  T. Davies,et al.  New insights into the thyroid-stimulating hormone receptor. The major antigen of Graves' disease. , 2000, Endocrinology and metabolism clinics of North America.

[29]  R. Latif,et al.  Fluorescent probes: looking backward and looking forward. , 2000, Thyroid : official journal of the American Thyroid Association.

[30]  U. Kumar,et al.  Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. , 2000, Science.

[31]  L. Devi,et al.  Recycling and resensitization of delta opioid receptors. , 2000, DNA and cell biology.

[32]  L. Devi,et al.  Opioid receptor endocytosis and activation of MAP kinase pathway. , 2000, Brain research. Molecular brain research.

[33]  U. Kumar,et al.  Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers* , 2000, The Journal of Biological Chemistry.

[34]  K. Blumer,et al.  G-protein-coupled receptors function as oligomers in vivo , 2000, Current Biology.

[35]  L. Devi,et al.  Role for C-tail residues in delta opioid receptor downregulation. , 2000, DNA and cell biology.

[36]  J. Wess,et al.  Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers* , 1999, The Journal of Biological Chemistry.

[37]  Alan Wise,et al.  Heterodimerization is required for the formation of a functional GABAB receptor , 1998, Nature.

[38]  Kuan-Teh Jeang,et al.  Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32* , 1997, The Journal of Biological Chemistry.

[39]  L. Devi,et al.  Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.

[40]  B. Smith,et al.  Understanding the thyrotropin receptor function-structure relationship. , 1997, Bailliere's clinical endocrinology and metabolism.

[41]  J. Parma,et al.  Constitutive activation of the TSH receptor by spontaneous mutations affecting the N‐terminal extracellular domain , 1997, FEBS letters.

[42]  E. Milgrom,et al.  Processing of the precursors of the human thyroid-stimulating hormone receptor in various eukaryotic cells (human thyrocytes, transfected L cells and baculovirus-infected insect cells). , 1994, European journal of biochemistry.

[43]  D. Russo,et al.  An insertion in the human thyrotropin receptor critical for high affinity hormone binding. , 1990, Science.

[44]  S. McLachlan,et al.  Autoantibodies to the thyrotropin receptor. , 1988, Endocrine reviews.

[45]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[46]  M. Bouvier,et al.  Structural and functional aspects of G protein-coupled receptor oligomerization. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[47]  S. Swillens,et al.  Activating mutations of the TSH receptor gene cause thyroid diseases. , 1996, Annales d'endocrinologie.